社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
点赞
1
回复
评论
收藏
编组 21备份 2
分享
矩形
faysl
08-08
礼来加仓机会,诺和诺德短时部分优势,市值研发还是礼来有未来
# 股价彻底反转?诺和诺德你的成本价是多少?
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
形状备份
1
举报
登录后可参与评论
评论
推荐
最新
暂无评论
热议股票
{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":465363524468760,"tweetId":"465363524468760","gmtCreate":1754639296191,"gmtModify":1754639298458,"author":{"id":3472536105367512,"idStr":"3472536105367512","authorId":3472536105367512,"authorIdStr":"3472536105367512","name":"faysl","avatar":"https://static.tigerbbs.com/1695dfcce74f75f324508f53af7967a5","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.06.05","exceedPercentage":"60.88%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":35,"starInvestorFlag":false},"themes":[{"themeId":"73e1dea489bd4d1b9c97363645435831","categoryId":"d316d8bd4a714fab9ea15fd7157c45e7","name":"股价彻底反转?诺和诺德你的成本价是多少?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":73e1dea489bd4d1b9c97363645435831}&rnconfig={\"headerBarHidden\": true}","description":"诺和诺德的减肥药Wegovy近日获美国FDA批准新用途,可用于治疗代谢功能障碍相关脂肪性肝炎(MASH),这一突破使诺和诺德在激烈的GLP-1药物市场竞争中,针对MASH领域抢占先发优势,以扭转年初以来的市值颓势。【大家觉得NVO是否已经彻底扭转局势?大家上车成本价都是多少?】","image":"https://static.tigerbbs.com/e4b46bcab7704932bd005a8ebd30a750"}],"images":[],"coverImages":[],"html":"<html><head></head><body><p>礼来加仓机会,诺和诺德短时部分优势,市值研发还是礼来有未来</p></body></html>","htmlText":"<html><head></head><body><p>礼来加仓机会,诺和诺德短时部分优势,市值研发还是礼来有未来</p></body></html>","text":"礼来加仓机会,诺和诺德短时部分优势,市值研发还是礼来有未来","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/465363524468760","repostId":0,"isVote":1,"tweetType":1,"viewCount":883,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":56,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}